Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results alongwith Limited Review Report for quarter & nine months ended as on December 31, 2025 and to transact other businesses.